Abstract:The genome-wide association studies (GWAS) have identified hundreds of susceptibility loci associated with autoimmune diseases. However, over 90% of risk variants are located in the noncoding regions, leading to great challenges in deciphering the underlying causal functional variants/genes and biological mechanisms. Previous studies focused on developing new scoring method to prioritize functional/disease-relevant variants. However, they principally incorporated annotation data across all cells/tissues while omitted the cell-specific or context-specific regulation. Moreover, limited analyses were performed to dissect the detailed molecular regulatory circuits linking functional GWAS variants to disease etiology. Here we devised a new analysis frame that incorporate hundreds of immune cell-specific multi-omics data to prioritize functional noncoding susceptibility SNPs with gene targets and further dissect their downstream molecular mechanisms and clinical applications for 19 autoimmune diseases. Most prioritized SNPs have genetic associations with transcription factors (TFs) binding, histone modification or chromatin accessibility, indicating their allelic regulatory roles on target genes. Their target genes were significantly enriched in immunologically related pathways and other immunologically related functions. We also detected long-range regulation on 90.7% of target genes including 132 ones exclusively regulated by distal SNPs (eg, CD28, IL2RA ), which involves several potential key TFs (eg, CTCF), suggesting the important roles of long-range chromatin interaction in autoimmune diseases. Moreover, we identified hundreds of known or predicted druggable genes, and predicted some new potential drug targets for several autoimmune diseases, including two genes ( NFKB1, SH2B3 ) with known drug indications on other diseases, highlighting their potential drug repurposing opportunities. In summary, our analyses may provide unique resource for future functional follow-up and drug application on autoimmune diseases, which are freely available at <http://fngwas.online/>. Author Summary Autoimmune diseases are groups of complex immune system disorders with high prevalence rates and high heritabilities. Previous studies have unraveled thousands of SNPs associated with different autoimmune diseases. However, it remains largely unknown on the molecular mechanisms underlying these genetic associations. Striking, over 90% of risk SNPs are located in the noncoding region. By leveraging multiple immune cell-specific multi-omics data across genomic, epigenetic, transcriptomic and 3D chromatin interaction information, we systematically analyzed the functional variants/genes and biological mechanisms underlying genetic association on 19 autoimmune diseases. We found that most functional SNPs may affect target gene expression through altering transcription factors (TFs) binding, histone modification or chromatin accessibility. Most target genes had known immunological functions. We detected prevailing long-range chromatin interaction linking distal functional SNPs to target genes. We also identified many known drug targets and predicted some new drug target genes for several autoimmune diseases, suggesting their potential clinical applications. All analysis results and tools are available online, which may provide unique resource for future functional follow-up and drug application. Our study may help reduce the gap between traditional genetic findings and biological mechanistically exploration of disease etiologies as well as clinical drug development.

Dissecting Regulatory Mechanisms Underlying Noncoding GWAS SNPs on 20 Autoimmune Disease

Dissecting molecular regulatory mechanisms underlying noncoding susceptibility SNPs associated with 19 autoimmune diseases using multi-omics integrative analysis

Multiomics dissection of molecular regulatory mechanisms underlying autoimmune-associated noncoding SNPs

Genetic and Epigenetic Fine Mapping of Causal Autoimmune Disease Variants.

Identification of the shared genetic architecture underlying seven autoimmune diseases with GWAS summary statistics

Refined Mapping of Autoimmune Disease Associated Genetic Variants with Gene Expression Suggests an Important Role for Non-Coding RNAs

A multilayered post‐GWAS analysis pipeline defines functional variants and target genes for systemic lupus erythematosus (SLE)

3D chromatin-based variant-to-gene maps across 57 human cell types reveal the cellular and genetic architecture of autoimmune disease susceptibility

DeepWAS: Multivariate Genotype-Phenotype Associations by Directly Integrating Regulatory Information Using Deep Learning

Integrative Data Analysis to Uncover Transcription Factors Involved in Gene Dysregulation of Nine Autoimmune and Inflammatory Diseases

Integrating Regulatory Features Data for Prediction of Functional Disease-Associated SNPs

Functional Relevance for Associations Between Genetic Variants and Systemic Lupus Erythematosus

Genetic Study of Complex Diseases in the Post-GWAS Era

From GWAS to Gene: Transcriptome-Wide Association Studies and Other Methods to Functionally Understand GWAS Discoveries

CRISPRa screen on a genetic risk locus shared by multiple autoimmune diseases identifies a dysfunctional enhancer that affects IRF8 expression through cooperative lncRNA and DNA methylation machinery

From GWAS to Function: Using Functional Genomics to Identify the Mechanisms Underlying Complex Diseases

Understanding the Function of Regulatory DNA Interactions in the Interpretation of Non-Coding GWAS Variants

Construction and Application of Polygenic Risk Scores in Autoimmune Diseases

Translation of genome-wide association study: from genomic signals to biological insights

Integrative Analyses for Functional Mechanisms Underlying Associations for Rheumatoid Arthritis

Interpretable GWAS by linking clinical phenotypes to quantifiable immune repertoire components